BioNTech SE (BVMF:B1NT34)

BioNTech SE Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	113,218	126,086	168,961	121,737	192,994	346,917
Market Cap Growth	-29.08%	-25.38%	38.79%	-36.92%	-44.37%	240.33%
Enterprise Value	29,612	33,787	55,379	41,890	124,802	333,306
Last Close Price	29.14	32.82	44.00	31.80	50.38	-
PE Ratio	-	-	-	24.40	3.62	5.32
PS Ratio	6.10	6.79	9.59	5.94	1.97	2.89
PB Ratio	0.91	1.01	1.36	1.12	1.70	4.60
P/TBV Ratio	1.01	1.13	1.45	1.19	1.72	4.68
P/FCF Ratio	62.32	69.41	-	4.43	2.58	71.83
P/OCF Ratio	38.39	42.76	127.04	4.23	2.52	61.54
EV/Sales Ratio	1.66	1.82	3.14	2.05	1.28	2.77
EV/EBITDA Ratio	-	-	-	7.04	1.84	3.53
EV/EBIT Ratio	-	-	-	8.04	1.85	3.54
EV/FCF Ratio	16.30	18.60	-	1.53	1.67	69.01
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-	-	-	0.19	0.02	0.02
Debt / FCF Ratio	0.95	0.95	-	0.04	0.02	0.40
Net Debt / Equity Ratio	-0.70	-0.70	-0.80	-0.81	-0.69	-0.15
Net Debt / EBITDA Ratio	11.99	11.99	13.27	-14.71	-1.16	-0.12
Net Debt / FCF Ratio	-47.96	-47.96	197.84	-3.19	-1.05	-2.33
Asset Turnover	0.13	0.13	0.12	0.17	0.89	2.09
Inventory Turnover	3.10	3.10	1.69	1.51	6.36	10.28
Quick Ratio	6.87	6.87	6.88	9.12	7.19	4.15
Current Ratio	7.54	7.54	7.45	9.43	7.43	4.33
Return on Equity (ROE)	-5.88%	-5.88%	-3.36%	4.62%	59.06%	155.18%
Return on Assets (ROA)	-3.56%	-3.56%	-3.53%	2.62%	38.09%	102.25%
Return on Invested Capital (ROIC)	-25.47%	-26.47%	-33.23%	15.07%	106.34%	195.58%
Return on Capital Employed (ROCE)	-6.40%	-6.40%	-6.40%	4.60%	58.60%	120.20%
Earnings Yield	-6.49%	-5.83%	-2.52%	4.10%	27.62%	18.80%
FCF Yield	1.60%	1.44%	-0.30%	22.56%	38.78%	1.39%
Buyback Yield / Dilution	-0.54%	-0.54%	0.95%	2.84%	3.81%	-4.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.